SEO URLwww.firestrike.ai/deals/dark-blue-therapeutics-ltd-amgen-acquisition-2026
acquisitionAnnounced · Jan 6, 2026biotechnologySource · CredibleArticle · Factual
Amgen acquires Dark Blue Therapeutics Ltd.
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
$840M
Target
Dark Blue Therapeutics Ltd.
Acquirer
Amgen
Full Acquisition
Status
Announced
Amgen agreed to acquire Dark Blue Therapeutics Ltd.. Reported deal value: $840M. Status: Announced. Sector: biotechnology. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-01-06. Figures and status may change as filings and press coverage update.
Amgen today announced its acquisition of Dark Blue Therapeutics Ltd. , a privately held biotechnology company based in the United
Deal timeline
Announced
Jan 6, 2026 · prnewswire.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in biotechnology with a reported deal value of $840M. Figures and status may change as sources update.
Sources: prnewswire.com · Primary article · FireStrike proprietary index